A federal appeals court in the US has declined to overturn an attempt by Novartis to block the launch of a generic version of its blockbuster heart failure drug Entresto. The US Court of Appeals for ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

It has been reported that Novo Nordisk may have inadvertently allowed generics of its GLP-1 agonist semaglutide, the active ingredient in diabetes therapy Ozempic and obesity drug Wegovy, into the ...

Discover the 10 best patch management software solutions for CIOs in 2025 to enhance cybersecurity, ensure compliance, and streamline update processes across enterprise infrastructures.

We independently evaluate all of our recommendations. If you click on links we provide, we may receive compensation. Learn what a crypto wallet is and how to create one Manoj is a writer who ...